Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma Touch Medical Media Services 38:53 2 weeks ago 64 Скачать Далее
Evolving Myeloma Treatment Options | Bispecific Antibody Therapy Patient Empowerment Network 7:15 4 months ago 67 Скачать Далее
The important role of bispecific antibodies in the future treatment of R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:54 1 year ago 93 Скачать Далее
The evolving treatment paradigm for relapsed/refractory multiple myeloma Touch Medical Media Services 36:34 2 years ago 43 Скачать Далее
Positioning immunotherapies in the changing paradigm of myeloma treatment VJHemOnc – Video Journal of Hematology & HemOnc 5:40 3 years ago 11 Скачать Далее
What Is the Role of Bispecific Antibody Therapy in the Future of Myeloma Care? Patient Empowerment Network 1:13 7 months ago 52 Скачать Далее
Accelerating Toward Curing Myeloma: New Data, New Agents, and Evolving Treatment Paradigm International Myeloma Foundation 2:47:42 3 years ago 8 945 Скачать Далее
How Is Bispecific Antibody Therapy Changing Myeloma Care? Patient Empowerment Network 1:52 1 year ago 18 Скачать Далее
Changes in the myeloma treatment paradigm VJHemOnc – Video Journal of Hematology & HemOnc 1:46 2 years ago 189 Скачать Далее
A comparison of bispecific antibodies emerging in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:20 2 years ago 253 Скачать Далее
Evolving treatment landscape for myeloma: ADCs VJHemOnc – Video Journal of Hematology & HemOnc 2:29 3 years ago 40 Скачать Далее
How are monoclonal antibodies changing the treatment paradigm for myeloma? Patient Power Europe 2:09 9 years ago 48 Скачать Далее
The evolution of the AML treatment paradigm VJHemOnc – Video Journal of Hematology & HemOnc 2:34 2 years ago 76 Скачать Далее
Outcomes in RRMM: The Modern Treatment Paradigm and BCMA Targeted Oncology 6:09 4 years ago 96 Скачать Далее
The evolving treatment landscape for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:30 3 years ago 85 Скачать Далее
The role of bispecific antibodies in the treatment of patients with multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:33 3 weeks ago 77 Скачать Далее
Efficacy and safety of elranatamab BCMA-CD3 bispecific antibody, in patients with RRMM International Myeloma Foundation 7:06 3 years ago 1 067 Скачать Далее
Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 35:50 6 years ago 5 196 Скачать Далее
